Background Use of muscle relaxants for tracheal intubation in pediatric patients been associated with significant side effects and complications during general anesthesia. Many anesthetic drug combinations have been used to facilitate intubation without the use of relaxants. Objectives To compare the efficacy of three different doses of Propofol to obtain optimum intubating conditions. Patients and Methods One hundred and four pediatric patients enrolled in our study after ethical committee approval and written parental consent. Patients were belonging to the American Society of Anesthesiologist physical status classes (I and II), aged from 18 months to 5 years, and were scheduled for tonsillectomy and/or adenoidectomy. Patients were pre-medicated with midazolam 0.2 mg/kg and ketamine 3 mg/kg 15-30 minutes before induction orally. Patients were randomly divided into 4 groups: Group I (control group) did not receive Propofol, while Group II, Group III, and Group IV received (1, 2 and 3 mg/kg of intravenous Propofol respectively). Cough, movement of the limb, tachycardia and smooth intubation condition had been recorded during intubation. Results Cough, movement of the limbs, tachycardia were mostly reported among the control group (100%, 74%, 43%) respectively. While smooth intubation condition was mostly among the group IV. 1mg/kg Propofol abolished cough response. 2mg/kg Propofol abolished movement of the limbs. 3 mg/kg Propofol was superior to 2 mg/kg Propofol in decreasing tachycardia response and smooth intubation condition. Conclusion Propofol in a dose of 3 mg/Kg I.V. is an excellent adjuvant drug for smooth intubation in children anesthetized with Sevoflurane.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.